Reply to thread

How would one know of a conditional approval? Abbott got the EU mark on Libre 3 almost a year and a half ago. It had a limited release in the EU (Germany). One poster suggested that the Libre 2 is making so much money that Abbott is not rushing the Libre 3 roll out in the EU. Also, the release in Germany gives time to discover and work out any technical and production issues. In the Q4 conference call Ford said the full rollout for Libre 3 will be in Q2 of this year. I am not aware of the FDA approval status of the FSL 3. DX needs to be careful of rushing the rollout of the F7....could have a shit storm of problems like the FSL1 did back in 2014.